FDA approves suzetrigine, a non-opioid pain reliever, as new alternative
Listen to article The US Food and Drug Administration (FDA) has approved a new pain medication, suzetrigine, marking the first new type of pain reliever to be approved in over 20 years. The drug, sold under the brand name Journavx, is a 50-milligram prescription pill taken every 12 hours after an initial larger dose. This approval introduces … Read more